Data DEBUG
Request:
https://api.data.payoff.ch/v2/strproducts/CH1422252150 Response:
{
"meta": {
"id": 27090708,
"categoryId": 12,
"subCategoryId": 1230,
"ibtTypeCode": 100060,
"hasMultipleUnderlyings": true,
"numUnderlyings": 2,
"issuerRef": "BKB",
"hasExtendedTradingHours": false,
"denomination": "1000.00000",
"productNameFull": "11.00% p.a. Multi Barrier Reverse Convertible on Eli Lilly, Novo Nordisk",
"guarantorRef": null
},
"basic": {
"isin": "CH1422252150",
"wkn": null,
"valor": "142225215",
"symbol": "CXABKB",
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"descriptionTemplate": "template-1230",
"termsheetUrlDe": "\/termsheets\/CH1422252150_de_20250715_003251.pdf",
"termsheetUrlEn": "\/termsheets\/CH1422252150_en_20250715_003820.pdf"
},
"highlights": {
"barrierRate": "59%",
"sidewardYieldMaturity": "1.35%",
"tradingCurrencyCode": "CHF"
},
"static": {
"categoryName": "Renditeoptimierung",
"subCategoryName": "Barrier Reverse Convertible",
"issuerName": "Basler Kantonalbank",
"issuerRatings": null,
"tradingCurrencyCode": "CHF",
"underlying": "Eli Lilly and Co \/ Novo Nordisk A\/S",
"tradingExchangeName": "SIX Structured Products",
"ratio": "1",
"isCollateralised": "Nein",
"issuePrice": "1'000.00",
"firstTradingDate": "14.07.2025",
"lastTradingDate": "07.07.2026",
"redemptionDate": "14.07.2026",
"paymentType": "bar oder physische Lieferung",
"mgmtFeePa": null,
"isCallable": "Ja",
"isAutoCallable": "Nein",
"optionStyle": "amerikanisch",
"couponRate": "11%",
"strikeRate": "100%",
"barrierRate": "59%",
"isQuanto": "Ja"
},
"market": {
"tradingExchangeName": "SIX Structured Products",
"tradingCurrencyCode": "CHF",
"bid": "72.39%",
"bidSize": "250'000",
"ask": null,
"askSize": "0",
"last": "72.95%",
"change": "+1.30",
"performanceWeek": "3.75%",
"performanceYtd": "-19.93%",
"lastDateTime": "24.06.2026 22:10:00"
},
"chart": [
{
"ttsId": "tts-820450",
"name": "Eli Lilly and Co"
},
{
"ttsId": "tts-209092551",
"name": "Novo Nordisk A\/S"
}
],
"keyfigures": {
"daysToMaturity": "12",
"distToBarrierRate": "16.45%",
"barrierHitProbMaturity": null,
"barrierHitProb10days": null,
"maxReturnMaturity": "41.94%",
"sidewardYieldMaturity": "1.35%",
"outperformanceLevel": null
},
"underlyings": [
{
"isin": "US5324571083",
"valor": "947556",
"name": "Eli Lilly and Co",
"symbol": "LLY",
"tradingExchangeName": "SIX Structured Products",
"tradingCurrencyCode": "USD",
"strikeLevel": "772.87",
"bid": "1'111.00",
"bidSize": "80",
"ask": "1'114.00",
"askSize": "40",
"last": "1'117.26",
"change": null,
"distToBarrier": "655.01",
"distToBarrierRate": "58.96%",
"lastDateTime": "24.06.2026 22:01:44"
},
{
"isin": "DK0062498333",
"valor": "129508879",
"name": "Novo Nordisk A\/S",
"symbol": "NOVOB",
"tradingExchangeName": "SIX Structured Products",
"tradingCurrencyCode": "DKK",
"strikeLevel": "441.20",
"bid": "311.55",
"bidSize": null,
"ask": "311.55",
"askSize": null,
"last": "310.30",
"change": null,
"distToBarrier": "51.24",
"distToBarrierRate": "16.45%",
"lastDateTime": "24.06.2026 17:00:45"
}
],
"similars": [
{
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"isin": "CH1390260128",
"symbol": "KZEHDU",
"categoryName": "Renditeoptimierung",
"issuerName": "UBS",
"isAd": false
},
{
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"isin": "CH1502675635",
"symbol": "LBJKDU",
"categoryName": "Renditeoptimierung",
"issuerName": "UBS",
"isAd": false
},
{
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"isin": "CH1481490071",
"symbol": "LAYDDU",
"categoryName": "Renditeoptimierung",
"issuerName": "UBS",
"isAd": false
}
],
"events": [
{
"type": "barrierhit",
"date": "22.02.2026"
}
]
}
CXABKB
Barrier Reverse Convertible auf Eli Lilly and Co / Novo Nordisk A/S
Das von Basler Kantonalbank emittierte Barrier Reverse Convertible eignet sich für chancenorientierte Investoren, welche kurzfristig eine Seitwärtsbewegung oder leicht positive Wertentwicklung der jeweiligen Basiswerte erwarten.
Stammdaten
- KategorieRenditeoptimierung
- TypBarrier Reverse Convertible
- EmittentBasler Kantonalbank
- HandelswährungCHF
- BasiswertEli Lilly and Co / Novo Nordisk A/S
- HandelsplatzSIX Structured Products
- Ratio1
- PfandbesichertNein
- Ausgabepreis1'000.00
- Erster Handelstag14.07.2025
- Letzter Handel07.07.2026
- Rückzahlungsdatum14.07.2026
- Auszahlungsartbar oder physische Lieferung
- CallableJa
- AutocallableNein
- Optionsstilamerikanisch
- Coupon11%
- Strike-Rate100%
- Barriere59%
- QuantoJa
Marktdaten
- BörsenplatzSIX Structured Products
- HandelswährungCHF
- Geldkurs72.39%
- Geld Volumen250'000
- Brief Volumen0
- Letzter Kurs72.95%
- Veränderung+1.30
- Performance (1 Woche)3.75%
- Performance YTD-19.93%
- Kurswerte vom24.06.2026 22:10:00
Kennzahlen
- Tage bis Verfall12
- Min. Abstand zur Barriere16.45%
- Maximalrendite (Verfall)41.94%
- Seitwärtsrendite (Verfall)1.35%
Chart
Basiswert: Eli Lilly and Co
- Eli Lilly and Co
- ISINUS5324571083
- Valor947556
- BasiswertEli Lilly and Co
- SymbolLLY
- BörsenplatzSIX Structured Products
- HandelwährungUSD
- Strike-Level772.87
- Geldkurs1'111.00
- Geld Volumen80
- Briefkurs1'114.00
- Brief Volumen40
- Letzter Kurs1'117.26
- Abstand zu Barrier655.01
- Distanz zur Barriere58.96%
- Kurswerte vom24.06.2026 22:01:44
Basiswert: Novo Nordisk A/S
- Novo Nordisk A/S
- ISINDK0062498333
- Valor129508879
- BasiswertNovo Nordisk A/S
- SymbolNOVOB
- BörsenplatzSIX Structured Products
- HandelwährungDKK
- Strike-Level441.20
- Geldkurs311.55
- Briefkurs311.55
- Letzter Kurs310.30
- Abstand zu Barrier51.24
- Distanz zur Barriere16.45%
- Kurswerte vom24.06.2026 17:00:45